Kieswetter NS, Ozturk M, Hlaka L, Chia JE, et al. Intranasally administered S-MGB-364 displays antitubercular activity and modulates the host immune response to Mycobacterium tuberculosis infection. J Antimicrob Chemother 2022 Jan 25. pii: 6515318. doi: 10.1093.
PMID: 35084027